Cornerstone Capital Management Holdings LLC. raised its stake in HealthSouth Corp (NYSE:HLS) by 41.4% in the 3rd quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor owned 120,545 shares of the company’s stock after buying an additional 35,264 shares during the quarter. Cornerstone Capital Management Holdings LLC. owned approximately 0.12% of HealthSouth worth $5,585,000 at the end of the most recent quarter.

A number of other large investors also recently modified their holdings of HLS. Advisor Group Inc. lifted its stake in shares of HealthSouth by 33.8% in the 2nd quarter. Advisor Group Inc. now owns 3,092 shares of the company’s stock valued at $149,000 after purchasing an additional 781 shares during the last quarter. Aviva PLC lifted its stake in shares of HealthSouth by 67.5% in the 2nd quarter. Aviva PLC now owns 43,670 shares of the company’s stock valued at $2,133,000 after purchasing an additional 17,600 shares during the last quarter. Schwab Charles Investment Management Inc. lifted its stake in shares of HealthSouth by 5.3% in the 2nd quarter. Schwab Charles Investment Management Inc. now owns 671,304 shares of the company’s stock valued at $32,492,000 after purchasing an additional 34,035 shares during the last quarter. Prudential Financial Inc. lifted its stake in shares of HealthSouth by 137.1% in the 2nd quarter. Prudential Financial Inc. now owns 434,679 shares of the company’s stock valued at $21,039,000 after purchasing an additional 251,372 shares during the last quarter. Finally, American International Group Inc. lifted its stake in shares of HealthSouth by 12.9% in the 3rd quarter. American International Group Inc. now owns 267,182 shares of the company’s stock valued at $12,384,000 after purchasing an additional 30,529 shares during the last quarter. Institutional investors own 93.37% of the company’s stock.

HealthSouth Corp (HLS) traded down $0.37 on Friday, reaching $49.40. The company had a trading volume of 1,180,700 shares, compared to its average volume of 901,328. HealthSouth Corp has a 1 year low of $38.24 and a 1 year high of $50.41. The company has a current ratio of 1.34, a quick ratio of 1.34 and a debt-to-equity ratio of 1.89. The firm has a market cap of $4,892.93, a price-to-earnings ratio of 17.84, a price-to-earnings-growth ratio of 1.83 and a beta of 0.54.

HealthSouth (NYSE:HLS) last posted its earnings results on Thursday, October 26th. The company reported $0.66 earnings per share (EPS) for the quarter, topping the Thomson Reuters’ consensus estimate of $0.65 by $0.01. HealthSouth had a return on equity of 22.81% and a net margin of 6.69%. The firm had revenue of $995.60 million for the quarter, compared to analyst estimates of $985.75 million. During the same quarter in the prior year, the company earned $0.65 EPS. HealthSouth’s revenue was up 7.4% on a year-over-year basis. research analysts anticipate that HealthSouth Corp will post 2.72 earnings per share for the current year.

The company also recently announced a quarterly dividend, which will be paid on Tuesday, January 16th. Investors of record on Tuesday, January 2nd will be paid a dividend of $0.25 per share. This represents a $1.00 annualized dividend and a yield of 2.02%. The ex-dividend date of this dividend is Friday, December 29th. HealthSouth’s payout ratio is 36.36%.

Several brokerages have recently commented on HLS. Robert W. Baird reaffirmed a “buy” rating and issued a $55.00 price target on shares of HealthSouth in a research note on Monday, October 9th. Zacks Investment Research raised HealthSouth from a “hold” rating to a “buy” rating and set a $52.00 price target on the stock in a research note on Monday, October 30th. William Blair reaffirmed an “outperform” rating on shares of HealthSouth in a research note on Tuesday, November 21st. KeyCorp reissued a “hold” rating on shares of HealthSouth in a research note on Thursday, September 7th. Finally, Royal Bank of Canada reissued a “buy” rating and set a $55.00 target price on shares of HealthSouth in a research note on Wednesday, September 6th. Two equities research analysts have rated the stock with a sell rating, four have given a hold rating and six have issued a buy rating to the stock. HealthSouth has an average rating of “Hold” and a consensus target price of $51.75.

In other news, Director Yvonne M. Curl bought 1,000 shares of the firm’s stock in a transaction that occurred on Wednesday, November 1st. The shares were purchased at an average price of $45.95 per share, with a total value of $45,950.00. Following the purchase, the director now owns 64,144 shares in the company, valued at $2,947,416.80. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. 1.60% of the stock is currently owned by corporate insiders.

TRADEMARK VIOLATION NOTICE: This news story was published by Watch List News and is the sole property of of Watch List News. If you are accessing this news story on another site, it was copied illegally and reposted in violation of United States and international copyright and trademark law. The correct version of this news story can be read at https://www.watchlistnews.com/cornerstone-capital-management-holdings-llc-has-5-59-million-holdings-in-healthsouth-corp-hls/1765830.html.

About HealthSouth

HealthSouth Corporation (HealthSouth) is a provider of post-acute healthcare services, offering both facility-based and home-based post-acute services in 35 states and Puerto Rico through its network of inpatient rehabilitation hospitals, home health agencies and hospice agencies. The Company manages its operations through segments, including inpatient rehabilitation, and home health and hospice.

Want to see what other hedge funds are holding HLS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for HealthSouth Corp (NYSE:HLS).

Institutional Ownership by Quarter for HealthSouth (NYSE:HLS)

Receive News & Ratings for HealthSouth Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HealthSouth and related companies with Analyst Ratings Network's FREE daily email newsletter.